Botox Timing: Starting, Spacing, and What “Preventative” Really Buys You

When to start, how often to repeat, and what the word preventative is actually describing. The mechanism is well understood; most of the confusion is about scheduling, and most of the marketing is about starting earlier.

Last reviewed 15 September 2026Reviewed quarterly
NeuromodulatorEvidenceMarketing claims
Dynamic line versus static lineThree panels of the same brow. In the first the face is at rest early on and there is no line. In the second the muscle is contracting and a deep vertical crease appears between the brows — a dynamic line. In the third the face is at rest years later and a faint crease remains, because the skin has been folded in the same place often enough to keep the record. That third state is a static line, and its arrival is the trigger for treatment rather than any particular age.At rest, earlyNothing at rest. The lineonly exists on movement.On movementThe muscle folds the skin.This is a dynamic line.At rest, laterA faint line remains. Thecrease is now in the tissue.Treating the movement changes the trajectory between the second panel and the third.
The test that decides when to start: make the expression, let go completely, and look again. A crease that fades is a muscle doing it. A crease that stays is the skin remembering.Illustration: facelove.info
Jump to

A neuromodulator does one thing: it stops a specific muscle from contracting as hard for about three months. Everything else people believe about it is downstream of that single fact, and most of the disagreement is about timing.

What "preventative" is describing

A line on your face exists in two forms. A dynamic line appears when the muscle underneath it contracts and disappears when it relaxes. A static line is visible when your face is at rest, because the skin has been folded in the same place often enough that the crease is now in the tissue itself.

Preventative treatment means treating the dynamic line before it becomes a static one. The claim is coherent — a crease that is folded less often is etched more slowly — and there is reasonable evidence for it, including long-term twin data where the treated twin had visibly fewer static lines years later.

What preventative does not mean is that starting at twenty-five delays aging in any general sense. It does nothing for volume, nothing for descent, nothing for skin quality, and nothing for the parts of your face where you do not want the muscle weakened.

When starting actually makes sense

The trigger worth watching for is not an age. It is a line that is still there after your face has gone back to neutral.

Look in a mirror, make the expression, then let go completely and look again. If the crease fades within a second or two, the muscle is causing it and the skin has not yet remembered it. If a faint line remains at rest, the skin is starting to keep a record, and that is the moment when treating the movement changes the trajectory.

For most people that happens somewhere between the early thirties and the mid forties, and it happens at different times in different areas of the same face. Plenty of people have an etched line between the brows and nothing at all across the forehead.

Spacing, and why three months is the number

The effect wears off because the nerve terminal grows new connections to the muscle. That takes roughly twelve weeks in most people, with a real range: some people run ten, some run sixteen.

Three practical points about spacing.

Chasing the very end of the effect is what causes the frozen look. If you book the moment you notice any movement returning, you are stacking. Most people do better letting it come part of the way back.

Treating more often than about ten weeks raises the risk of antibodies. Neutralizing antibodies are uncommon, but the two things that make them more likely are short intervals and high doses. That is a reason to space, and a reason to be skeptical of a plan that involves topping up between appointments.

Longer intervals are usually fine. If you go six months between treatments, you have not undone anything. You have simply had less coverage during the gap.

The areas that need a different conversation

Dose and placement matter more than schedule in a few specific places.

The forehead muscle is the only thing holding your brows up. Weakening it too much, or too low, drops the brow and hoods the eye — and the person it happens to most often is someone in their fifties who already has a little brow descent. In that face, treating the forehead aggressively makes the eyes look heavier, and the fix is a lighter hand rather than more product elsewhere.

Around the mouth, in the neck, and along the jaw, the muscles are doing more work than most people realize. These are the areas where an experienced injector is worth paying for, and where "a few units to soften it" is a sentence that deserves a follow-up question about which muscle and how many units.

What it will not do

It will not lift a jowl or a brow that has descended structurally. It will not change skin texture, pigmentation or the crepey quality of thin skin. It will not soften a line that is already deeply etched at rest, though it will stop it deepening further, and resurfacing or a small amount of filler in the crease can address what remains.

Being clear about that list is what keeps expectations sensible, because almost every disappointing neuromodulator result I see is a treatment that was asked to solve a problem in a different category.

The version I would give a friend

Start when a line persists at rest, not on a birthday. Treat the areas that are actually creasing. Space treatments about three months apart and let a little movement return before the next one. Expect it to do exactly one thing well, and plan the rest of your face separately.

The verdicts on this

All verdicts
ModestEvidence grade BSkin & Prevention

Red Light Therapy

Real but small, and only with consistent use at an adequate dose.

Last reviewed 15 September 2026

Recent coverage

All news
NewsInjectables1 September 2026

A Randomized Trial of Lower-Face Neuromodulator Dosing

A randomized, double-blind trial in the Aesthetic Surgery Journal mapped injection points and escalating doses for botulinum toxin in the lower face. The lower face is where the muscles are doing more work than most people realize, and where a few units in the wrong place changes a smile rather than a line. Mapped dosing studies are how that becomes a technique rather than an individual injector's preference.

Aesthetic surgery journal, “Injection Mapping and Dose Escalation For Botulinum Toxin Treatment on the Lower Face: A Randomized, Double-blind Clinical Trial.” — read the original

Related guides

All guides
GuideFacelift & Neck

Deep Plane or SMAS: What Actually Differs, and Who Each One Suits

Both operations are called facelifts and both are done by good surgeons. The difference is which anatomical layer carries the lift, and that one decision changes the look, the durability, the scar and the risk profile.

Last reviewed 15 September 2026

Newsletter

The one email a week that isn't selling you something.

What changed in facial rejuvenation this week, one guide we updated, and why it matters. Written by Jay Keni, MD.

A weekly email, once we launch it. We don’t sell or share addresses, and we never add patients from practice records — privacy.

Found something out of date, or something we got wrong? How we handle corrections.